Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.
about
Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adultsMu-opioid antagonists for opioid-induced bowel dysfunctionMu-opioid antagonists for opioid-induced bowel dysfunctionDelayed gastrointestinal recovery after abdominal operation - role of alvimopanTreatment of opioid-induced gut dysfunctionAlvimopan (entereg) for the management of postoperative ileus in patients undergoing bowel resectionAlvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis.Novel opioid antagonists for opioid-induced bowel dysfunction.Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database.Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative IleusAlvimopan addition to a standard perioperative recovery pathwayPharmacological management to prevent ileus in major abdominal surgery: a systematic review and meta-analysis.Alvimopan Use, Outcomes, and Costs: A Report from the Surgical Care and Outcomes Assessment Program Comparative Effectiveness Research Translation Network Collaborative.Management of postoperative ileus: focus on alvimopan.Postoperative ileus: strategies for reduction.A review of irritable bowel syndrome and an update on therapeutic approaches.Alvimopan (Entereg), a Peripherally Acting mu-Opioid Receptor Antagonist For Postoperative Ileus.Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.Pharmacological management of postoperative ileus.Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.The opioid component of delayed gastrointestinal recovery after bowel resection.Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies.Immunosuppressive effects of opioids--clinical relevance.Pharmacologic management of postoperative nausea and vomiting.Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery.New therapeutic strategies for postoperative ileus.Methylnaltrexone for the treatment of opioid-induced constipation.Defining postoperative ileus: results of a systematic review and global survey.Reducing the burden of postoperative ileus: evaluating and implementing an evidence-based strategy.The use of alvimopan for postoperative ileus in small and large bowel resections.Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol.Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era.Does alvimopan enhance return of bowel function in laparoscopic gastrointestinal surgery? A meta-analysis.Alvimopan Use, Outcomes, and Costs: In reply to Fujita.On "pathogenesis and management of postoperative ileus" (clin colon rectal surg 2009;22:47-50)Fast track colorectal surgery.Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways.The effects of a short course of antibiotics on alvimopan and metabolite pharmacokinetics.Clinical practice guideline for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
P2860
Q24242508-24B44E0B-7077-4459-9E4F-AC9A78ECF119Q24243268-2FEC1111-CB13-4444-984D-44318705FD4BQ24243361-60B0819B-F824-4A1A-9FD3-922DFD597C24Q26861398-7D63AA0C-E6E8-49C6-A52C-C38F27023060Q28284578-F75C0F1F-BF2C-4549-953A-556F5558656EQ33628991-AB66EF7C-C90B-4CD0-95F1-4B05BDF3152FQ34050269-7087F1B0-7514-4D07-80A5-E9A7F927264EQ34191604-F13A17CF-BB1D-4983-9E82-10A1D61E4CF5Q34906614-A1C5C1BE-D466-4F34-886D-DFD80876725AQ35202119-EFD77650-B11D-4E38-B581-DA3C867972A6Q35924640-BAD356E6-4C70-4A2D-B619-DB0B3C7DD29AQ35987949-05AF0317-9B3B-4FE7-9A7A-81E115935A21Q36845583-C7D01158-2CF6-44C5-BD4E-45BE22590EC2Q37052834-E39E47D5-32B0-4EDA-B888-CDDA8D54957BQ37052842-BF48A088-F282-465F-8B8C-47B59F54D896Q37142056-0AAABC53-D94F-4DD5-9566-0C0776664ACFQ37315521-74A6AEC9-BB74-4306-9073-9A66B2C27B27Q37426287-DC3ACFDC-6BD6-4B23-91B5-6CF719363F6FQ37462197-50C3D936-F776-4CE0-98B9-C35048623BE1Q37491434-A1083754-35A6-42F8-9D34-6C586C206400Q37790838-512C1FB5-B4FF-4D30-BADD-DD70516E08CDQ37865426-6116699B-9175-45FB-8142-2193AACD6D82Q37880195-3F3AC3E1-7FFF-4510-A151-DA6E79155BFCQ37897497-059ED1A7-2436-49D8-8EB2-DCE0E4328E3BQ37901057-91C28525-1452-4475-BEEF-32D0FC94DB24Q38008608-A202D87A-A525-40D2-836D-6CF36E9CAEDEQ38026765-760D2991-F5B3-4C81-90A8-C026C30417B8Q38069607-61D8A4F7-8DB2-405A-8862-7B76B3139AB8Q38078828-384F7F3B-C5E9-4382-AF26-10134BBB3732Q38200504-41280EFA-8234-47E2-B1DE-4B4041BA4396Q38612972-EBDB0179-AAEA-4CDB-9834-913E08F43BE1Q38820188-2FB57336-1BC8-493C-9DAA-3D97F4158E5EQ38913953-D694D317-1AA3-4462-BB1A-E9A26C11214FQ38958130-1C47BA65-E380-4A22-99ED-A8D97CE68114Q42333606-72E86CB6-B8E9-4D50-8E67-602369FFAFE4Q42392133-BB51B195-9B0D-4D19-88EC-33216B13AF39Q42653359-95ACE93E-0061-4409-BEC1-583D39B15C37Q42792091-660F371B-66B3-4D71-B9AA-D0F369F771B8Q43268377-F5B79759-2753-4AC8-A71A-0968CBCB040BQ44071872-058467DF-4C58-4CEE-A1D5-31D53408F971
P2860
Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@en
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@nl
type
label
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@en
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@nl
prefLabel
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@en
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@nl
P2093
P1433
P1476
Alvimopan, a peripherally acti ...... ouble-blind, controlled study.
@en
P2093
A Andonakakis
E R Viscusi
S Goldstein
T Witkowski
P2888
P356
10.1007/S00464-005-0104-Y
P407
P577
2005-12-07T00:00:00Z